Lisanti Capital Growth, LLC Rocket Pharmaceuticals, Inc. Transaction History

Lisanti Capital Growth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$27.42 - $48.97 $4.93 Million - $8.8 Million	-179,705 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $1.08 Million - $1.29 Million	27,287 Added 17.9%	179,705 $7.96 Million
Q1 2021 May 12, 2021	BUY	$43.34 - $65.91 $1.64 Million - $2.49 Million	37,850 Added 33.04%	152,418 $6.76 Million
Q4 2020 Feb 10, 2021	BUY	$23.3 - $59.57 $735,348 - $1.88 Million	31,560 Added 38.02%	114,568 $6.28 Million
Q3 2020 Nov 05, 2020	BUY	$20.5 - $28.59 $1.7 Million - $2.37 Million	83,008 New	83,008 $1.9 Million

Q2 2020 Aug 10, 2020	SELL	$13.32 - $22.61 $518,281 - $879,755	-38,910 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$9.71 - $25.11 $259,159 - $670,185	26,690 Added 218.41%	38,910 $543,000
Q4 2019 Feb 13, 2020	BUY	$11.07 - $24.23 $135,275 - $296,090	12,220 New	12,220 $278,000

204

92.9M

341K

107K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.51B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.